Skip to main content
Premium Trial:

Request an Annual Quote

Novogene Gets CLIA Certification for US Lab

NEW YORK (GenomeWeb) – Beijing-based sequencing service provider Novogene announced today that it has received CLIA certification for its US clinical laboratory.

The lab is located within Novogene's sequencing center at the Sacramento campus of the University of California, Davis. The company opened the center in early 2016 to provide its US and global customers with whole-genome sequencing services for human, plant, and animal samples for biomedical and agricultural research.

"CLIA certification is an important milestone for Novogene, allowing us to provide genomic solutions not only for scientific research, but also for clinical testing," David Jiang, general manager of clinical and consumer genomic solutions at Novogene, said in a statement. "We are excited to offer our clinical partners high-quality sequencing services at low cost with fast turnaround time."

In addition to its facilities in China and the US, Novogene also operates a sequencing lab in Singapore.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.